Photo of laboratory research on medicine with scientific equipment and chemical glassware representing scientific discovery and medical research
Webinars

Advancing the drug discovery and development pipeline

Join this two-day event to learn where drug development is headed and what it means for researchers today.

 Live Symposium

Drug discovery and development continue to evolve as advances in molecular biology, computational tools, and translational science reshape how therapies progress from early research to clinical evaluation. Increasing biological complexity, data integration challenges, and evolving regulatory expectations are influencing how researchers identify targets, optimize candidates, and design clinical studies.

This two-day symposium will bring together leading experts discussing emerging strategies, technologies, and collaborations that are transforming drug discovery and development across the pharmaceutical industry.

Topics to be covered:

  • AI-driven drug discovery and molecular design
  • New approach methodologies for preclinical research
  • Advanced bioprocessing and therapeutic platforms
  • High-throughput and automated approaches for lead optimization
  • Digital transformation of lab workflows

View Agenda

Wednesday May 27th - Thursday May 28th, 2026 
11:00 AM - 3:00 PM ET
This symposium will be available to view live and on demand.

Speakers

Joseph C. Wu, MD, PhD

Joseph C. Wu, MD, PhD
Director, Stanford Cardiovascular Institute
Simon H. Stertzer, MD, Professor of Medicine and Radiology
Stanford University

Jonathan Stokes, PhD

Jon Stokes, PhD
Assistant Professor
Department of Biochemistry and Biomedical Sciences
McMaster University

Paula Meleady, PhD

Paula Meleady, PhD
Associate Professor
School of Biotechnology
Dublin City University

Peter Madrid, PhD

Peter Madrid, PhD
Head of Scientific Development
Synfini

Lorna Ewart, PhD

Lorna Ewart, PhD
Chief Scientific Officer
Emulate

Jeremy Jones, PhD

Jeremy Jones, PhD
Principal Scientist, AIDD Applications
Simulations Plus

Chunling Xuan, PhD

Chunling Xuan, PhD
Director, Lentiviral Vector Process Development
ProBio

Peter Chapple, PhD

Peter Chapple, PhD
Global Product Manager, Catalysis, Platforms & Kits
MilliporeSigma (Merck KGaA, Darmstadt, Germany)

Yujie Chen, PhD

Yujie Chen, PhD
NGS Scientist
Takara Bio USA

Mark Griener, PhD

Mark Griener, PhD
Digital Innovation Manager
MilliporeSigma (Merck KGaA, Darmstadt, Germany)

David Gosalvez, PhD

David Gosalvez, PhD
Chief Strategy Officer
Revvity Signals

Dan Goldstaub, PhD

Dan Goldstaub, PhD
Scientific Co-Founder
PhaseV

Elena Puris, PhD

Elena Puris, PhD
Senior Researcher
University of Eastern Finland


Executive Sponsor

ProBio

Premium Sponsors

Shimadzu
Takara Bio
Revvity Signals
MilliporeSigma

Standard Sponsors

BD Bio
Syncell
BioXCell
BellBrook Labs
Thermo Fisher Scientific


Top Image Credit:

iStock: Artsanova